Tag: research papers

No comments

Epigenetic Changes in Sperm May Explain Association Between Paternal Age and Autism Risk

  By

“Research findings suggest that advanced paternal age is associated with an increased risk of autism spectrum disorder (ASD) in children.”

While maternal health has traditionally been central to research on pregnancy and child development, there is growing recognition that paternal factors also play a role, particularly the father’s age. Several studies have found a modest increase in risk of neurodevelopmental conditions, including autism spectrum disorder, among children born to older fathers. However, the biological mechanisms underlying this association are still not fully understood.

One emerging explanation involves epigenetics, chemical modifications that influence how genes are expressed without altering the underlying DNA sequence. Among these is DNA methylation. Earlier studies have suggested that sperm from older men may carry age-related changes in DNA methylation, but few have explored these patterns on a genome-wide scale or focused specifically on regions that are most likely to influence offspring development.

The Study: Exploring Age-Dependent Methylation at Imprint Control Regions in Human Sperm

In a study, titled “Age-specific DNA methylation alterations in sperm at imprint control regions may contribute to the risk of autism spectrum disorder in offspring,” published in Aging-US and selected as the Editors’ Choice for January, 2026, researchers investigated how DNA methylation patterns in sperm change with age. The study was led by first authors Eugenia Casella and Jana Depovere, with corresponding author Adelheid Soubry from the University of Leuven.

The research focused specifically on imprint control regions (ICRs), genetic segments that regulate gene activity based on whether the genes are inherited from the mother or the father. These regions play a crucial role during early development and have been associated with developmental disorders when improperly regulated.

To conduct the analysis, the team examined sperm samples from 63 healthy, non-smoking men aged 18 to 35 years.

The Results:  Age-Dependent Epigenetic Changes in Sperm Detected Near Autism-Associated Genes

The researchers identified over 14,000 DNA sites (known as CpG sites) where methylation levels were significantly correlated with age. Most of these sites had reduced methylation in older individuals. Of particular interest were 747 sites near known imprint control regions, areas essential for regulating gene expression during early development. When cross-referenced with public databases of autism-associated genes, several of these age-sensitive sites overlapped with genes previously linked to autism spectrum disorder, including MAGEL2, DLGAP2, GNAS, KCNQ1, and PLAGL1.

The Breakthrough: Focus on Imprint Control Regions Reveals Epigenetic Role of Paternal Age

By concentrating on regions of the genome that remain active during the earliest stages of embryonic development, this study provides new evidence supporting the idea that paternal age may influence a child’s developmental outcomes through epigenetic changes in sperm, not just through genetic mutations. This is a step forward in understanding how non-genetic information carried by sperm can affect offspring.

The Impact: Findings Expand Understanding of Paternal Contributions to Offspring Health

These findings should not be interpreted as a reason for older men to avoid fatherhood. Rather, the study refines the understanding of the biological mechanisms that may contribute to autism risk and underscores the importance of considering paternal factors in reproductive health discussions. The research may support future studies aimed at developing early diagnostic tools, risk assessments, or potential interventions. However, such applications are still far from clinical use and require further validation.

Future Perspectives and Conclusion

This study adds to a growing body of evidence suggesting that age-related changes in sperm may play a role in the health of future generations. It is important to note that the observed DNA methylation changes were modest and, on their own, are unlikely to determine whether a child develops autism. Further research, particularly studies that follow these epigenetic patterns through conception, pregnancy, and child development, will be essential to assess their practical significance.

Overall, this work contributes to the broader understanding of reproductive planning and paternal health, offering a more complete picture of the factors that may influence child development.

Click here to read the full research paper published in Aging-US.

___

Aging-US is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed Central, Web of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Click here to subscribe to Aging-US publication updates.

For media inquiries, please contact [email protected].

No comments

Chocolate Compound Linked to Slower Biological Aging

  By

“Theobromine, a commonly consumed dietary alkaloid derived from cocoa, has been linked to extended lifespan in model organisms and to health benefits in humans.”

When we think of aging, we often picture wrinkles or gray hair. But aging also occurs deep within our cells. One key area of research focuses on “epigenetic aging,” the gradual changes in how DNA is regulated over time. These changes are tracked using tools called epigenetic clocks, which estimate a person’s biological age based on specific molecular markers in the blood. Unlike chronological age, biological age reflects the body’s functional state and can be influenced by health, lifestyle, and environmental factors.

While chocolate and coffee have been associated with better health outcomes, pinpointing the responsible specific compounds has been difficult. These foods contain multiple bioactive substances that are often consumed together, and few studies have explored their individual effects on the human epigenome, the system of chemical modifications that control gene activity and change with age.

A recent study provides new insight, suggesting that theobromine, a compound naturally found in cocoa, may be associated with slower biological aging in humans.

The Study: Investigating Theobromine and Epigenetic Aging in TwinsUK and KORA Cohorts

The research titled “Theobromine is associated with slower epigenetic ageing,” was led by Ramy Saad from King’s College London and Great Ormond Street Hospital for Children NHS Foundation Trust, alongside Jordana T. Bell from King’s College London. The study was recently published in Aging-US. 

The team analyzed blood sample data from over 1,600 healthy individuals in two large population-based studies: TwinsUK in the United Kingdom and KORA in Germany. They investigated six compounds commonly found in coffee and cocoa, including caffeine, theophylline, and theobromine, to assess their potential relationship with two well-established epigenetic aging measures: GrimAge, which estimates the risk of early death, and DNAmTL, which reflects telomere length, a marker of cellular aging.

Results: Higher Theobromine Levels Are Associated With Slower Biological Aging

The study found that individuals with higher blood levels of theobromine had slower biological aging, as measured by both GrimAge and DNAmTL. This suggests that their cellular and molecular profiles appeared younger than their chronological age. The initial findings from the female twin cohort in the UK were confirmed in Germany’s KORA cohort that includes a larger and more diverse population.

Importantly, the researchers accounted for other compounds commonly found in cocoa and coffee, such as caffeine, and still observed the same effect. The association remained significant even after adjusting for variables such as diet quality and smoking history. Interestingly, the effect was particularly notable in individuals who had previously smoked. The researchers also ruled out potential biases related to differences in the timing of sample collection.

Breakthrough: Theobromine Shows a Unique Link to Slower Epigenetic Aging

Theobromine appeared to act independently of other similar molecules and showed a specific association with slower epigenetic aging. While structurally similar to caffeine, theobromine behaves differently in the body and is found in higher concentrations in cocoa-rich foods like dark chocolate. Previous research has associated it with improvements in blood pressure and cognitive function, but this study is among the first to connect it with molecular markers of aging.

Impact: Theobromine Identified as a Potential Dietary Target for Healthy Aging

If validated by future studies, theobromine could emerge as a promising target for dietary or therapeutic strategies aimed at supporting healthy aging. The findings strengthen the growing understanding that specific dietary components can influence the aging process, not only through visible, external signs, but also at the molecular and cellular levels. While theobromine is abundant in cocoa products, the study does not advocate increased chocolate consumption. Instead, it highlights the potential role of naturally occurring plant-based compounds in modulating biological aging and contributing to long-term health.

Future Perspectives and Conclusion

As with all observational studies, this research establishes association rather than causation. More studies, particularly randomized clinical trials, will be needed to determine whether increasing theobromine intake can directly slow biological aging.

Nevertheless, the results suggest that theobromine may be one reason cocoa-rich diets have been linked with cardiovascular and cognitive benefits. As scientific interest grows in how nutrition influences epigenetic aging, compounds like theobromine may play an increasingly important role in understanding and potentially extending human healthspan.

Click here to read the full research paper published in Aging-US.

___

Aging-US is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed Central, Web of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Click here to subscribe to Aging-US publication updates.

For media inquiries, please contact [email protected].

No comments

EDITORS’ CHOICE: Age-specific DNA methylation alterations in sperm at imprint control regions may contribute to the risk of autism spectrum disorder in offspring

  By

Each month, we will highlight a paper published in Aging-US chosen as the “Editors’ Choice.” These selections are handpicked by our editors and accompanied by a brief summary, showcasing research with significant impact and novel insights in aging and age-related diseases.


The results of studies revealed in the paper published in Volume 17, Issue 12, titled “Age-specific DNA methylation alterations in sperm at imprint control regions may contribute to the risk of autism spectrum disorder in offspring,” indicate that advanced paternal age increases the risk of autism spectrum disorder (ASD) in children, potentially due to sperm epigenetic changes.

To explore this, the authors performed an epigenome-wide association study on sperm from 63 men using the Illumina 450K array, identifying 14,622 age-related differentially methylated CpGs (DMCs), with many linked to imprinted genes and imprint control regions (ICRs). These alterations may disrupt gene expression and contribute to neurodevelopmental disorders like ASD. Several imprinted genes identified—including OTX1, PRDM16, and others—are associated with ASD, warranting further research into their role in paternal age effects on autism.

Further genetic research may clarify how paternal age affects autism. Changes in DNA methylation within ICRs before conception could add to ASD’s complexity. Though measured effects were small, even minor sperm epigenetic changes could influence populations as fatherhood is delayed. Preventive and educational programs could benefit public health.

Click here to read the full research paper published in Aging-US.

______

To learn more about the journal, please visit www.Aging-US.com​​ and connect with us on social media:

Click here to subscribe to Aging-US publication updates.

For media inquiries, please contact [email protected].

No comments

A Common Aging Pattern: Changes in RNA Splicing and Processing Across Human Tissues

  By

“Although transcriptomic changes are known to occur with age, the extent to which these are conserved across tissues is unclear.”

As we age, every tissue in the body undergoes gradual molecular changes. A long-standing question in aging research is whether these changes follow common patterns across tissues or whether each tissue ages on its own. While DNA-based “epigenetic clocks” can estimate age accurately across different tissues, identifying consistent patterns in gene expression has been much more challenging.

One reason for this difficulty is methodology. Most studies focus on whether genes increase or decrease their expression levels with age. However, genes do not function in isolation. They operate within complex networks, coordinating their activity with many others. Changes in these relationships may be important aspects of the aging process. 

To understand this, researchers from the University of São Paulo performed a study titled “A combination of differential expression and network connectivity analyses identifies a common set of RNA splicing and processing genes altered with age across human tissues.”

The Study: Gene Expression and Network Analysis Integration to Study Aging Across Human Tissues

Featured on the cover of Aging-US (Volume 17, issue 12), the study analyzed gene expression data from nearly 1,000 donors from the Genotype-Tissue Expression (GTEx) project. They focused on 8 tissues (blood, brain, adipose tissue, muscle, blood vessel, heart, skin, and esophagus) from individuals aged 20 to 70. 

Rather than relying only on traditional differential expression analysis, the team combined this approach with gene network analysis. This allowed them to check not only how strongly genes were expressed, but also how their patterns of coordination with other genes changed across aging. By integrating these two perspectives, the researchers aimed to capture age-related transcriptomic changes that might otherwise go undetected.

Results: Aging Alters Gene Networks and RNA Processing Across Human Tissues

The results revealed a clear and consistent pattern. Many genes showed little or no change in their average expression levels with age, yet their connectivity within gene networks changed substantially. In other words, aging often altered how genes interacted with one another rather than simply how active they were.

When gene expression and network connectivity were analyzed together, a core group of genes emerged as altered with age across nearly all studied tissues. These shared genes were not randomly distributed across biological functions. Instead, they were strongly enriched in processes related to RNA splicing and RNA processing, the steps that convert raw RNA transcripts into mature messages used to produce proteins.

These genes were also highly interconnected in protein–protein interaction networks, indicating that they function together as part of coordinated molecular systems. Many are components of known cellular complexes involved in RNA handling, suggesting that aging affects not just individual genes but entire functional groups.

Breakthrough: Network Analysis Reveals Hidden Conserved Aging Signatures Across Tissues

This study demonstrates that network-based analyses can uncover conserved aging-related changes that are largely invisible when analyzing gene expression alone. This approach helps explain why previous studies often failed to identify shared aging signatures across tissues.

Impact: Network Reorganization in RNA Processing Associated to Key Aging Mechanisms

Errors in RNA splicing can lead to the production of abnormal or malfunctioning proteins, which tend to accumulate as cells age. The study shows that tissues appear to respond to this by reorganizing networks involved in RNA processing, protein quality control, and degradation pathways such as autophagy. These coordinated changes align with well-known features of aging, including declining protein homeostasis.

Importantly, this network-based perspective helps reconcile conflicting findings in earlier research. Different tissues may show distinct gene-level changes, yet still be responding to the same underlying molecular stresses through different regulatory strategies.

Future Perspectives and Conclusion

This research highlights RNA splicing and processing as central and conserved features of transcriptomic aging across human tissues. It also underscores the importance of studying gene networks, rather than focusing exclusively on individual genes, when investigating complex biological processes such as aging.

While further work is needed to determine whether these changes actively drive aging or reflect adaptive responses to accumulating cellular damage, the findings offer a more integrated perspective on how aging develops at the molecular level. Ultimately, this knowledge may help guide strategies aimed at supporting healthier aging across multiple tissues rather than targeting isolated organs or pathways.

Click here to read the full research paper published in Aging-US.

___

Aging-US is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed Central, Web of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Click here to subscribe to Aging-US publication updates.

For media inquiries, please contact [email protected].

No comments

Using Machine Learning to Identify Senescence-Inducing Drugs for Resistant Cancers

  By

“Senescence identification is rendered challenging due to a lack of universally available biomarkers.”

Treating aggressive cancers that do not respond to standard therapies remains one of the most significant challenges in oncology. Among these are basal-like breast cancers (BLBC), which lack hormone receptors and HER2 amplification. This makes them unsuitable for many existing targeted treatments. As a result, therapeutic options are limited, and patient outcomes are often poor.

One emerging strategy is to induce senescence, a state in which cancer cells permanently stop dividing but remain metabolically active. This approach aims to slow or stop tumor growth without killing the cells directly. Although promising, the clinical application of senescence-based therapies has been limited by several challenges.

Senescence is typically identified using biomarkers such as p16, p21, and beta-galactosidase activity. However, these markers are often already present in aggressive cancers like BLBC (Sen‑Mark+ tumors), making it difficult to determine whether a treatment is truly inducing senescence or merely reflecting the tumor’s existing biology. Moreover, conventional screening methods may mistake reduced cell growth for senescence, cell death, or temporary growth arrest, leading to inaccurate assessments. This is especially problematic in large-scale drug screening, where thousands of compounds must be evaluated quickly and reliably.

To overcome these issues, researchers from Queen Mary University of London and the University of Dundee have developed a new machine learning–based method to improve the detection of senescence in cancer cells. Their findings were recently published in Aging-US.

The Study: Developing the SAMP-Score

The study, titled “SAMP-Score: a morphology-based machine learning classification method for screening pro-senescence compounds in p16-positive cancer cells,” was led by Ryan Wallis and corresponding author Cleo L. Bishop from Queen Mary University of London. This paper was featured on the cover of Aging-US Volume 17, Issue 11, and highlighted as our Editors’ Choice.

The research team developed a tool called SAMP-Score. To build the model, the researchers applied high-content microscopy, image analysis, and unsupervised clustering to identify subtle morphological changes and patterns associated with true senescence. The team referred to these patterns as senescence-associated morphological profiles (SAMPs). These patterns were then used to train a machine learning algorithm capable of distinguishing senescent, non-dividing cells from those that were still proliferating or undergoing cell death.

After validation on the MB-468 cell line (a p16-positive basal-like breast cancer model), the model was applied to a large-scale screen of 10,000 experimental compounds across multiple cell lines: MB-468, HeLa, BT-549 (all p16-positive), and HCT116 p16 knockout (p16-negative).

Results: QM5928 Identified as a Pro-Senescence Agent

From the screening, the team identified a compound referred to as QM5928, which showed the ability to induce senescence in p16-positive cancer cells. The response was dose-dependent: at lower concentrations, it reduced cell proliferation without signs of toxicity, indicating senescence; at higher concentrations, toxicity began to appear. This suggests that the compound induces senescence rather than directly causing cell death.

Importantly, the researchers also observed a relocation of p16 into the nucleus, a sign that senescence-related cell cycle arrest mechanisms may be engaged. In contrast, the effect of QM5928 was reduced in a p16-negative cell line, supporting the idea that p16 plays a key role in the compound’s activity.

Breakthrough: The Innovation Behind SAMP-Score

The main innovation in this study is not just the identification of QM5928 as a promising compound but the development of a reliable and scalable method for detecting senescence in cancer cells. By combining high-content image analysis with machine learning, SAMP-Score provides an alternative to traditional marker-based methods, which can give ambiguous results in aggressive cancers. This approach reduces false positives and improves the accuracy of drug screening by better distinguishing compounds that truly induce senescence.

Impact: Implications for Cancer Drug Discovery

SAMP-Score provides a practical and scalable tool for discovering drugs in cancer types where conventional senescence markers do not offer clear results. This is particularly valuable in cancers like BLBC, which have high p16 expression but few effective targeted treatments. In the future, SAMP-Score may also help design combined therapies that first induce senescence, then eliminate senescent cells using senolytics.

Future Perspectives and Conclusion

While QM5928 remains in the early stages of investigation, it serves as a proof of concept for how the SAMP-Score method can support the discovery of pro-senescence compounds. Further studies will be necessary to clarify the compound’s mechanism of action and evaluate its effects in more complex models.

The broader impact of this work lies in its methodological contribution. By moving beyond biochemical markers and using image-based classification, SAMP-Score offers a practical and scalable way to improve senescence detection, particularly in cancers where current screening methods are unreliable.

Importantly, the researchers have made SAMP-Score openly available on GitHub, allowing others to apply or adapt the tool in their own senescence-related research.

Click here to read the full research paper published in Aging-US.

___

Aging-US is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed Central, Web of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Click here to subscribe to Aging-US publication updates.

For media inquiries, please contact [email protected].

No comments

Alpha-Synuclein Overexpression in Rats Reveals Early Clues to Synucleinopathies

  By

“Synucleinopathies are age-dependent neurodegenerative diseases characterized by alpha-synuclein accumulation with distinct vulnerabilities across brain regions.”

Synucleinopathies are a group of age-related neurological disorders, including Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. Most individuals are not diagnosed until these diseases have significantly progressed, as early symptoms, such as a reduced sense of smell, subtle cognitive or motor changes are too vague to serve as reliable indicators. 

To uncover specific biological signs that appear earlier and clearly point to the disease process, researchers from Saarland University developed a study titled “Brain region-specific and systemic transcriptomic alterations in a human alpha-synuclein overexpressing rat model,” featured as the cover of Aging-US, Volume 17, Issue 10.

Understanding Synucleinopathies

Synucleinopathies are characterized by the abnormal buildup of the protein alpha-synuclein in the brain. When this protein misfolds, it accumulates inside neurons and forms toxic clumps that disrupt their normal function and threaten cell survival. Because brain samples from patients are usually obtained only after death, scientists rely on animal models to investigate how these diseases start and progress.

The Study:  Exploring Early Gene Changes Associated with Synucleinopathies

A research team from Saarland University, led by Vivien Hoof and Thomas Hentrich, studied a genetically engineered rat model that overexpresses the human form of alpha-synuclein. Their goal was to examine how this protein affects gene activity in both the brain and the gut at different life stages.

The researchers focused on three brain regions known to be involved in movement and cognition: the striatum, cortex, and cerebellum. They examined gene expression in rats at two ages, at five and twelve months, representing early and mid-adulthood, roughly equivalent to young and middle-aged humans. Gut tissue was also studied to better understand the possible systemic effects of alpha-synuclein accumulation.

The Results: Early and Widespread Gene Changes Across the Brain and Gut

The study revealed that gene activity was more significantly disrupted in younger rats, particularly in the striatum, a key area for motor control. Many of the affected genes were involved in communication between nerve cells, suggesting that vital brain functions start shifting early in the disease process.

In older rats, changes were especially noticeable in the cortex and related to myelination, the process that insulates nerve fibers. Similar patterns have also been observed in patients with synucleinopathies, highlighting the value of the rat model.

Importantly, the team identified a core group of genes that were consistently altered across all three brain regions. Some of these same gene changes were also found in the gut, suggesting that the impact of alpha-synuclein accumulation is not limited to the brain but may influence the entire nervous system, including the enteric (gut) nervous system.

The Breakthrough: Evidence That Synucleinopathies May Begin Long Before Symptoms Appear

This study provides compelling evidence that synucleinopathy-related changes begin early at the molecular level, well before clinical symptoms emerge, challenging the notion that such diseases only manifest in later life. These early alterations are both brain region-specific and systemic. The presence of similar gene changes in the gut supports the growing understanding that synucleinopathies are not just brain disorders, but may affect the entire body. These early molecular signals could serve as biomarkers, helping to detect disease before lasting damage occurs.

The Impact: Opening New Paths for Early Detection and Intervention

These findings could shift research toward diagnosing synucleinopathies in their earliest stages. If similar patterns of gene activity can be identified in humans, potentially through blood or stool samples, it may be possible to detect these diseases years before symptoms arise. Early detection could enable timely and more effective treatment.

The study also sheds light on previously overlooked genes involved in neuroprotection and neural communication, which may become new targets for therapeutic development.

Future Perspectives and Conclusion

While synucleinopathies are often seen as diseases of aging, this study highlights that crucial biological changes may occur far earlier. Mapping these early molecular changes provides a strong foundation for developing new diagnostic tools and early-stage treatments. It also reinforces the need to study not just the brain but the entire nervous system, including the gut, which may serve as an accessible window into early disease processes.

Click here to read the full research paper published in Aging-US.

___

Aging is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed Central, Web of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Click here to subscribe to Aging publication updates.

For media inquiries, please contact [email protected].

No comments

How Long-Term Social Connection Supports Brain Health and Memory in Aging

  By

“While environmental enrichment (EE) can protect against cognitive deficits in old age, whether EE with long-term social housing provides greater protection than EE alone, and the underlying neuronal mechanisms, remain unknown.”

As people age, it is common to experience some memory lapses or slower thinking. Although this is often a normal part of aging, it can still affect a person’s quality of life. Scientists have been investigating ways to slow or prevent cognitive decline, and growing evidence points to the potential role of social interaction.

Recently, a study using rats found that long-term social connection may help protect the brain from age-related memory decline. This work, titled “The impact of long-term social housing on biconditional association task performance and neuron ensembles in the anterior cingulate cortex and the hippocampal CA3 region of aged rats,” was recently published in Aging-US (Volume 17, Issue 9).

The Study: How Long-Term Social Connection Influences the Aging Brain 

Previous studies have shown that environmental enrichment, such as physical activity and cognitive challenges, can support brain health. However, it has been less clear whether social living, on its own, provides additional benefits. To address this question, a research team led by Anne M. Dankert from Providence College and the University of North Carolina at Chapel Hill investigated how long-term social housing affects memory and brain activity in aging rats.

The researchers divided the animals into three groups: young rats, aged rats that were housed alone, and aged rats that were housed with companions throughout life. All aged rats had access to physical and cognitive enrichment, but only one group also experienced long-term social interaction.

The study focused on two areas of the brain that are involved in memory and decision-making: the anterior cingulate cortex (ACC), which is associated with attention and behavioral control, and the hippocampal CA3 region, which is essential for forming and distinguishing between similar memories.

The Results: Long-Term Social Connection Supports Memory and Brain Function in Aging Rats

The aged rats that lived in social groups performed significantly better on tasks involving memory and decision-making compared to those that were housed alone. In a challenging task that required the animals to associate specific objects with their correct locations in a maze, only the socially housed aged rats performed at a level similar to that of young rats. The isolated aged rats made more errors and showed signs of cognitive decline.

In addition to behavioral results, the researchers found differences in brain activity. The socially housed aged rats showed stronger activation in the hippocampal CA3 region during testing, which suggests better memory function. At the same time, their ACC was less overactive during simpler tasks, indicating more efficient brain activity. 

The Breakthrough: Social Interaction Promotes Better Brain Function in Rats

This study provides evidence that sustained social interaction may help preserve brain function during the aging process. Unlike previous research that often combined social factors with other types of environmental enrichment, this work isolated the effect of long-term social housing on memory and brain activity. The findings show that even when other enriching elements—such as physical and cognitive stimulation—are present, the addition of social living offers distinct cognitive and neural benefits. 

The Impact: Rethinking the Role of Social Life in Healthy Aging

This study supports the idea that social connection could be an important factor in maintaining brain health. If social interaction alone provides measurable benefits—even when other forms of enrichment are present—it reinforces the value of strong social bonds in later life. Social programs, family engagement, and opportunities for daily interaction may play a key role in protecting cognitive abilities in older adults.

Future Perspectives and Conclusion

Although the study was conducted in rats, the findings are consistent with previous human research suggesting that social engagement supports brain health. Future research can explore how these effects translate to people and whether specific types or durations of social interaction are more effective.

Overall, this work shows that long-term social connection may help preserve memory and support more efficient brain function during aging. Maintaining close relationships may therefore be a valuable and practical approach to supporting cognitive health in older adults.

Click here to read the full research paper published in Aging-US.

___

Aging is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed Central, Web of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Click here to subscribe to Aging publication updates.

For media inquiries, please contact [email protected].

No comments

New Anti-Aging Combo Boosts Lifespan in Old Male Mice

  By

“Extending lifespan and healthspan remains a central goal of biomedical research and has been tackled through numerous and diverse approaches.”

As life expectancy increases, there is growing interest not only in extending lifespan but also in improving the quality of those additional years. To address the physical and cognitive decline that often accompanies aging, researchers have explored a variety of strategies. Many of these focus on a single biological factor, such as reducing inflammation or stimulating stem cell activity. However, aging is a complex process involving multiple, interconnected changes in the body.

Recognizing this, researchers at the University of California, Berkeley proposed a more comprehensive approach: targeting multiple aging-related pathways simultaneously. Their study, titled “Sex-specific longitudinal reversal of aging in old frail mice,” was recently featured on the cover of Aging-US (Volume 17, Issue 9).

The Study: A Dual Treatment Using Oxytocin and an Alk5 Inhibitor

In this study, a team led by first author Cameron Kato and corresponding author and Aging-US Editorial Board member Irina M. Conboy tested a combination treatment on very old and frail mice, roughly equivalent in age to 75-year-old humans. The treatment involved two compounds: oxytocin, a hormone that naturally declines with age and is involved in tissue repair and regeneration, and an Alk5 inhibitor, which blocks part of the TGF-β signaling pathway. This pathway often becomes overactive in older individuals, contributing to inflammation and impaired tissue function.

The researchers aimed to determine whether targeting both the declining and overactive systems at the same time would be more effective than addressing just one.

The Results: Distinct Effects in Male and Female Mice

In male mice, the results were notable. Lifespan increased by 14 percent when measured from birth, and by over 70 percent when measured from the start of treatment in old age. These mice also showed improved physical performance, including better endurance, strength, and memory. Even after reaching a certain level of frailty, they continued to live longer than untreated mice, suggesting that the treatment not only prolonged life but also helped maintain function.

In contrast, the same treatment did not improve lifespan or general health in female mice. However, when administered to middle-aged females, the treatment enhanced fertility. This suggests that biological sex and timing may significantly influence how the treatment works.

The Impact: Multi-Target Strategies for Addressing Aging

Although this research was conducted in mice, it adds valuable insight to a growing field focused on coordinated, multi-target approaches to aging. Both oxytocin and Alk5 inhibitors are already being studied or used in clinical settings for other conditions, which means their safety profiles are at least partially understood. This opens the door for future studies exploring whether similar treatments could be applied to human aging.

Future Perspectives and Conclusion

This study presents a promising model for how aging could be addressed through balanced therapeutic strategies. It also highlights the importance of understanding sex-specific responses to treatment. The effectiveness of the therapy in males, and the fertility response in females, point to the need for personalized approaches in future research.

While more studies are necessary to determine whether these findings can be translated to humans, the results suggest that even in later stages of life, it may be possible to improve health and resilience by restoring balance in the body’s signaling systems.

Click here to read the full research paper published in Aging-US.

___

Aging is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed Central, Web of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Click here to subscribe to Aging publication updates.

For media inquiries, please contact [email protected].

No comments

AI Tools Reveal How IPF and Aging Are Connected

  By

“Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterized by the excessive accumulation of extracellular matrix components, leading to declining lung function and ultimately respiratory failure.”

Idiopathic Pulmonary Fibrosis (IPF) is a progressive lung disease that primarily affects people over the age of 60. It causes scarring in the lung tissue, which gradually reduces lung capacity and makes breathing difficult. Despite years of research, the exact causes of IPF remain largely unknown, and current treatments mainly aim to slow its progression rather than reverse or cure the disease.

Because IPF tends to develop later in life, researchers have long suspected a connection with biological aging. This is the focus of a recent study by scientists from Insilico Medicine. Their research, titled “AI-driven toolset for IPF and aging research associates lung fibrosis with accelerated aging,” was published recently in Aging-US, Volume 17, Issue 8.

The Study: Using AI to Explore the Link Between IPF and Aging

To investigate the biological relationship between IPF and aging, researchers Fedor Galkin, Shan Chen, Alex Aliper, Alex Zhavoronkov, and Feng Ren, from Insilico Medicine, developed two artificial intelligence (AI) tools. The first, a proteomic aging clock, estimates a person’s biological age using protein markers found in blood samples. The second, a specialized deep learning model named ipf-P3GPT, was trained to analyze patterns of gene activity in both normal aging and fibrotic lung tissue.

The aim was to explore whether IPF mirrors biological aging or whether it follows a separate disease pathway. While aging and IPF share common features, such as chronic inflammation and tissue damage, it is not yet clear if IPF is simply accelerated aging or a distinct biological process. Distinguishing between the two is essential for developing more targeted and effective treatments.

To train the aging clock, the team used the UK Biobank collection of over 55,000 proteomic Olink NPX profiles, annotated with age and gender. They then applied the model to patients with severe COVID-19, a population known to be at higher risk of developing lung fibrosis. In parallel, the ipf-P3GPT model simulated and analyzed gene expression patterns in lung tissue, allowing the team to directly compare the biological signatures of aging and IPF.

Results: IPF and Aging Are Distinct Biological Entities

The aging clock accurately estimated biological age in healthy individuals. When applied to patients with severe COVID-19, the clock predicted higher biological ages compared to healthy controls. This finding suggests that fibrotic lung conditions may be linked to accelerated biological aging and that such changes leave a detectable molecular signature in the body.

Using the ipf-P3GPT model, the researchers found that while 15 genes were shared between lung tissue affected by normal aging and IPF, more than half of these genes displayed opposite patterns of activity, being upregulated in aging but downregulated in IPF, or vice versa. These results indicate that IPF is not merely a faster version of aging but a distinct biological condition influenced by age-related dysfunction and unique molecular alterations.

The Impact: Toward Better Understanding and Treatment of Fibrotic Diseases

A key insight from this study is that although aging and IPF are biologically related, they follow different molecular pathways. IPF involves changes in gene expression and tissue remodeling that go beyond the patterns typically seen in normal aging. This difference could guide the development of therapies that specifically target fibrosis without interfering with healthy aging processes.

The AI tools developed in this research also have broader potential. The aging clock could be used to identify individuals whose biological age is advancing more quickly due to hidden disease processes, even before symptoms appear. At the same time, ipf-P3GPT provides a framework for studying how aging and disease interact on a molecular level, which could be applied to other age-related or fibrotic conditions such as liver or kidney fibrosis.

By combining AI with large-scale biological data, this approach introduces a powerful toolset that supports more personalized treatment strategies and a better understanding of age-related disease mechanisms.

Future Perspectives and Conclusion

While the results are promising, further validation is needed. Both models should be tested across diverse patient datasets and clinical settings to confirm their reliability and usefulness. Still, this study highlights how AI can support medical research by uncovering subtle biological differences between aging and disease.

Overall, this study establishes novel connections between IPF disease and aging biology while demonstrating the potential of AI-guided approaches in therapeutic development for age-related diseases. By helping scientists better understand where aging ends and disease begins, these AI tools may contribute to earlier diagnosis, more accurate monitoring, and improved treatment strategies for patients facing fibrotic and age-related conditions.

Click here to read the full research paper published in Aging-US.

___

Aging is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed Central, Web of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Click here to subscribe to Aging publication updates.

For media inquiries, please contact [email protected].

No comments

How Exosomes Spread Aging Signals and Could Support Anti-Aging Research

  By

“Senescent cells release a senescence-associated secretory phenotype (SASP), including exosomes that may act as signal transducers between distal tissues, and propagate secondary senescence.”

As the global population grows older, understanding what drives the aging process is becoming increasingly important. Diseases like Alzheimer’s, cardiovascular conditions, and cancer are more common with age, yet many current treatments only manage symptoms rather than addressing the underlying biological causes.

One contributor to aging is the buildup of “senescent” cells—cells that have stopped dividing but do not die. These cells can harm nearby tissues by releasing molecular signals, a process known as secondary senescence.

Scientists have found that senescent cells release tiny particles called exosomes. A research team from The Buck Institute for Research on Aging recently discovered that these exosomes carry aging-related messages through the bloodstream. Their study, titled “Exosomes released from senescent cells and circulatory exosomes isolated from human plasma reveal aging-associated proteomic and lipid signatures,” was featured as the cover article in Aging (Aging-US), Volume 17, Issue 8.

The Study: Exosomes and Aging

The team led by Sandip Kumar Patel, Joanna Bons, and Birgit Schilling from The Buck Institute for Research on Aging focused their study on exosomes—tiny, bubble-like structures released by cells that carry proteins, lipids, and genetic material. These particles can move through the bloodstream and influence distant tissues. 

The researchers wanted to know whether exosomes from senescent cells and from the blood of older adults shared common markers of aging. Since aging cells are spread throughout the body and lack a single clear marker, exosomes could provide a new way to detect their presence through a simple blood test.

To explore this, the team analyzed exosomes from two sources: lab-grown human lung cells that had undergone senescence and blood samples from both young (20–26 years old) and older (65–74 years old) adults. They used high-throughput mass spectrometry.

Results: Exosomes Reveal Signs of Aging

In total, the team identified over 1,300 proteins and 247 lipids within the exosomes. Specifically, 52 proteins appeared in both senescent cells and the blood plasma of older adults, many of which are associated with inflammation and tissue damage. Some examples include Prothrombin, Plasminogen, and Reelin—molecules involved in blood clotting, tissue remodeling, and neural development. Their presence in both aged blood and senescent cells suggest a broader impact of aging on multiple biological systems.

The team also observed significant changes in the lipid content of the exosomes. Lipids that help maintain cell membrane structure were more common in samples from older individuals, while lipids involved in energy storage were less abundant.

In addition, the researchers detected changes in microRNAs—small pieces of genetic material that regulate gene expression. Several microRNAs found in the blood of older adults have already been associated with diseases such as Alzheimer’s and osteoarthritis.

The Impact: Potential for Diagnostics and Anti-Aging Therapies

This study is among the first to directly compare exosomes from senescent cells and human plasma, revealing shared aging-related markers across biological systems.

These particles act like messengers, spreading signals that may accelerate aging in other cells. This supports the concept of secondary senescence—where aging-like behavior is transmitted from senescent cells to healthy ones—suggesting that exosomes may help propagate aging throughout tissues over time.

This work could lead to the development of blood tests that measure biological age more accurately than a person’s chronological age. It might also help clinicians monitor the effectiveness of anti-aging treatments.

Future Perspectives and Conclusion

Although the study involved a small number of human samples, it presents a promising new approach to studying aging. If confirmed in larger studies, the findings could lead to improved diagnostic tools and therapies for age-related diseases.

In the long term, researchers may explore ways to block or modify harmful exosome signals to protect healthy cells from premature aging. These molecular signatures could also support personalized medicine approaches or help track the effectiveness of anti-aging interventions in clinical settings.

Click here to read the full research paper published in Aging (Aging-US).

___

Aging is indexed by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed Central, Web of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Click here to subscribe to Aging publication updates.

For media inquiries, please contact [email protected].

  • Follow Us